Back To Results

Guidelines *CME

September 25, 2019

An Introspective View of Biologics Used for Psoriatic Disease (CME)

Episode 37

Hear Dr. Alan Menter, Chief of Dermatology at Baylor, Scott and White Health in Dallas, Texas, and Co-Chair of the Guidelines Development Committee, discuss the 11 biologic agents used for the treatment of moderate-to-severe psoriasis and psoriatic arthritis.

Access the guidelines.

To view disclosure information and claim credit, visit this page.

This podcast is supported by unrestricted educational grants from Celgene and Ortho Dermatologics.

Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2020 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.